Benefit-risk tradeoff preferences for chronic hand eczema treatments

Hand eczema affects approximately 16% of the US population. The long-term prognosis is poor, and 5–7% experience severe chronic hand eczema (sCHE) that interferes with daily activities. Treatments for CHE may be ineffective or associated with adverse events (AEs) that may dissuade patients from purs...

Full description

Bibliographic Details
Main Authors: A. Brett Hauber, Ateesha F. Mohamed, Juan Marcos Gonzalez, Angelyn Otteson Fairchild, Susan C. Zelt, Ole Graff
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2016.1177161